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Abstract
Introduction The aim was to investigate the relationship of
cartilage loss (change in medial femorotibial cartilage thickness
measured with magnetic resonance imaging (MRI)) with
compartment-specific baseline radiographic findings and MRI
cartilage morphometry features, and to identify which baseline
features can be used for stratification of fast progressors.
Methods An age and gender stratified subsample of the
osteoarthritis (OA) initiative progression subcohort (79 women;
77 men; age 60.9 ± 9.9 years; body mass index (BMI) 30.3 ±
4.7) with symptomatic, radiographic OA in at least one knee was
studied. Baseline fixed flexion radiographs were read centrally
and adjudicated, and cartilage morphometry was performed at
baseline and at one year follow-up from coronal FLASH 3 Tesla
MR images of the right knee.
Results Osteophyte status at baseline was not associated with
medial cartilage loss. Knees with medial joint space narrowing
tended to show higher rates of change than those without, but
the relationship was not statistically significant. Knees with
medial femoral subchondral bone sclerosis (radiography),
medial denuded subchondral bone areas (MRI), and low
cartilage thickness (MRI) at baseline displayed significantly
higher cartilage loss than those without, both with and without
adjusting for age, sex, and BMI. Participants with denuded
subchondral bone showed a standardized response mean of up
to -0.64 versus -0.33 for the entire subcohort.
Conclusions The results indicate that radiographic and MRI
cartilage morphometry features suggestive of advanced disease
appear to be associated with greater cartilage loss. These
features may be suited for selecting patients with a higher
likelihood of fast progression in studies that attempt to
demonstrate the cartilage-preserving effect of disease-
modifying osteoarthritis drugs.
Introduction
The Osteoarthritis (OA) Initiative is a program targeted at char-
acterizing risk factors associated with the onset and progres-
sion of symptomatic knee OA and at identifying sensitive
biomarkers of symptomatic knee OA. To this end, fixed flexion
radiography [1-5] and 3 Tesla magnetic resonance imaging
ANOVA: analysis of variance; BMD: bone mineral density; BMI: body mass index; ccMF: central aspect of the weight bearing medial femoral condyle; 
cMF: weight bearing medial femoral condyle; cMFTC: central medial femorotibial compartment; cMT: central medial tibia; FLASH: fast low angle shot; 
GLM: general linear models; JSN: joint space narrowing; JSW: joint space width; KLG: Kellgren Lawrence grade; MFTC: medial femorotibial com-
partment; mJSN: medial joint space narrowing; MRI: magnetic resonance imaging; MT: medial tibia; OA: osteoarthritis; SRM: standardized response 
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(MRI) scans [6-8] were performed at baseline and at regular
follow-up in 4796 participants. We [9,10] and others [11]
have recently reported a modest (but significant) change in
femorotibial cartilage morphology over one year in the first
publicly released longitudinal data in an age- and gender-strat-
ified subcohort of 160 participants [12]. Potential predispos-
ing factors of subsequent cartilage loss, including age, sex,
body mass index (BMI), symptom status, and the Kellgren
Lawrence grade (KLG), were assessed. Cartilage loss was
found to be more prominent in the medial (than in the lateral)
femorotibial compartment, and more prominent in the weight-
bearing femur than in the tibia [9-11]. Participants with high
BMI and radiographic OA (as determined by the KLG [13])
were observed to display trends toward higher rates of change
than those with lower BMI and without radiographic OA [9],
although the relation failed to reach statistical significance.
The limitation of the KLG [13], however, is that it mixes distinct
constructs (osteophytes, joint space narrowing (JSN),
subchondral sclerosis, subchondral bone shape changes,
cysts, etc) into one scale with the invalid assumptions that
changes are linear [14].
In addition, the KLG is not specific to the medial or lateral fem-
orotibial compartment. The association of compartment-spe-
cific baseline MRI cartilage morphology measures with
longitudinal cartilage loss has not been previously investigated
in this cohort. An accurate stratification during study recruit-
ment with regard to 'progressors' with relatively rapid cartilage
loss is, however, important, because the potential therapeutic
effect of a disease-modifying OA drug can be demonstrated
using much lower sample sizes if only participants with a high
likelihood of fast progression are recruited.
The objective of the current study was therefore to determine
whether compartment-specific individual radiographic fea-
tures (JSN, osteophytes, sclerosis, and others) at baseline,
and compartment-specific structural status of the knee carti-
lage in MRI (specifically denuded subchondral bone area and
cartilage thickness) are predictive of longitudinal medial femo-
rotibial cartilage thickness loss over one year.
Materials and methods
An age- and gender-stratified subsample (OA Initiative public-
use datasets 0.1.1, 0.B.1, and 1.B.1) of the OA Initiative pro-
gression subcohort was studied, with the exclusion criteria (i.e.
rheumatoid or inflammatory arthritis, bilateral end stage knee
OA, inability to walk without aids, and 3 Tesla MRI contraindi-
cations) and other details having been described previously
[9]. The OA Initiative is conducted in compliance with the eth-
ical principles derived from the Declaration of Helsinki and in
compliance with local Institutional Review Board, informed
consent regulations, and International Conference on Harmo-
nization Good Clinical Practices Guidelines.
The subsample studied included 79 women with a mean ±
standard deviation age of 60.3 ± 9.5 years and BMI of 30.3 ±
5.5, and 77 men with an age of 62.0 ± 10.2 years and BMI of
30.1 ± 3.7. The age range examined was 45 to 79 years. All
participants had frequent knee symptoms, and radiographic
OA, as defined by definite osteophytes in the postero-anterior
fixed flexion radiographs [1,2] in at least one knee from the
clinical site readings.
The current analysis relied on the results of the independent
radiographic readings by a musculoskeletal radiologist and
rheumatologist, which in cases of discrepancy were adjudi-
cated by consensus with a third reader. The following features
were graded on the baseline radiograph based on the Oste-
oarthritis Research Society International atlas: medial and lat-
eral JSN (graded 0 to 3) [15,16]; medial and lateral tibial and
femoral osteophytes (graded 0 to 3) [15,16]; medial and lat-
eral tibial and femoral subchondral sclerosis (graded 0 to 3)
[15,16]; medial and lateral tibial subchondral bone attrition
(graded 0 to 3) [15,16]; medial and lateral tibial and femoral
cysts (graded 0 or 1); medial and lateral compartment chon-
drocalcinosis (graded 0 or 1).
The MRI sequence used to quantify cartilage morphology (see
below) was only acquired in the right knees [17], whereas
some participants displayed symptoms and radiographic OA
in their left knee. As a result of this and because the adjudi-
cated central radiographic readings may have differed from
the initial screening readings, not all knees analyzed had radi-
ographic (or symptomatic) knee OA. Of the 156 right knees
analyzed, 17 (11%) were KLG 0, 29 (19%) KLG1, 56 (36%)
KLG 2, 47 (30%) KLG 3, and 7 (4%) were KLG 4.
MRI was performed using four 3 Tesla scanners (Siemens
Magnetom Trio, Erlangen, Germany) and quadrature transmit-
receive knee coils (USA Instruments, Aurora, OH, USA). Dou-
ble oblique coronal 3D fast low angle shot (FLASH) MRI with
water excitation were acquired as described previously [6-9]
(Figure 1). After initial quality control at the image analysis
center (Chondrometrics GmbH, Ainring, Germany), manual
segmentation of the femorotibial cartilages was performed by
seven technicians with at least three years of experience in
cartilage segmentation [6-9,18] (Figure 1). The image data
were processed in pairs (baseline and one year follow up), the
readers being blinded to the order of the image acquisition.
Because of the higher rate of change in the medial compart-
ment that was reported previously [9,11], and because of the
relatively few subjects with lateral radiographic femorotibial
OA (see below), medial cartilage loss was used as an out-
come measure (Figure 1). However, knees with predominantly
lateral radiographic OA were not eliminated from the study.
Specifically, we analyzed one year changes in the mean carti-
lage thickness over the total subchondral bone area (ThCtAB)
in the medial tibia (MT), central (weight bearing) medial femo-Available online http://arthritis-research.com/content/11/3/R90
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ral condyle (cMF [6,7]; Figure 1), and medial femorotibial com-
partment (MFTC = summed values of MT and cMF).
As changes in central subregions of the above plates were
shown to display greater changes than the total cartilage
plates in this subcohort [10], we also considered the central
tibia (cMT, covering the central 20% of the subchondral bone
area), the central weight-bearing medial femur (ccMF, cover-
ing 33%) and the central MFTC (cMFTC = sum of cMT and
ccMF) as outcome measures [19] (Figure 2). The mean
change, standard deviation of change, standardized response
mean (SRM), and the significance of the change (two sided
paired t-test, without correction for multiple testing) were cal-
culated for each measure. The SRM provides a measure of the
'sensitivity to change' and was computed by dividing mean
change in a given group or subgroup by the standard deviation
of the change in this group or subgroup. A negative SRM
expresses cartilage loss, and the greater (more negative) the
SRM, the greater and more uniform is the cartilage loss in a
given group or subgroup. The mean percentage change was
calculated by relating the mean change (in mm) in all knees to
the mean baseline values of all knees.
The following baseline features of quantitative MRI of cartilage
morphology were examined in the context of predicting
change: mean cartilage thickness over the total subchondral
bone area (ThCtAB) in MT, cMF, and MFTC, and presence of
a denuded area of more than 1% of the total subchondral bone
area in MT, cMF, or MFTC. Percentage values in MT and cMF
were added to provide a measure of denuded bone area in
MFTC. The cut-off value of more than 1% was chosen to
exclude small areas of an uncovered total area of subchondral
bone (three cases in MT, no case in cMF) that may potentially
result from small imaging artifacts.
Analysis of variance (ANOVA) was used first to test whether
categorical features of structural knee status in fixed flexion
radiographs or MRI cartilage morphometry (JSN, osteophytes,
subchondral sclerosis, presence of denuded areas of
subchondral bone) were significantly associated with cartilage
loss over one year, as measured in absolute thickness change
(mm). General linear models (GLM) were then used to assess
the relation of these features with cartilage loss after adjusting
Figure 1
Knee magnetic resonance image obtained with fast low angle shot  (FLASH) sequences with water excitation Knee magnetic resonance image obtained with fast low angle shot 
(FLASH) sequences with water excitation. (a) Double oblique coronal 
image showing the regions of interest used in the current analysis. (b) 
Same coronal image with the total area of subchondral bone (tAB) 
being segmented in green, the area of the cartilage surface (AC) in 
magenta, and the filling between the two surfaces in turquoise. Note 
the denuded area (tAB not covered by AC) in the medial tibia and the 
medial femur. (c) Same coronal image with the medial tibial (MT) carti-
lage marked (segmented) blue, weight-bearing medial femoral cartilage 
(cMF) marked yellow, the lateral tibial cartilage marked green, and the 
lateral weight-bearing femoral cartilage marked red. (d) 3D reconstruc-
tions of knee cartilage plates from a sagittal data set in a different per-
son: The femoro-tibial cartilages are labeled with the same colors as in 
(c), the patellar cartilage is labeled magenta and the trochlear (femoral) 
cartilage in turquoise.
Figure 2
Cartilage plates and subregions used as outcome measures in this  study Cartilage plates and subregions used as outcome measures in this 
study. (a) Inferior view of the weight-bearing (central) part of the medial 
(cMF) and lateral femoral condyle (cLF). ccMF = central third of cMF 
(icMF and ecMF = internal and external third of cMF, respectively). (b) 
Posterior view of the femorotibial joint. MFTC = cMF + MT; cMFTC = 
ccMF + cMT. (c) Superior view of the medial (MT) and lateraltibia (LT). 
cMT = central part of MT (iMT, eMT, aMT, and pMT = internal, external, 
anterior, and posterior parts of MT, respectively).Arthritis Research & Therapy    Vol 11 No 3    Eckstein et al.
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for age, sex, and BMI, and to test whether the continuous var-
iable 'ThCtAB at baseline' was significantly associated with
cartilage loss.
Results
Structural changes in fixed flexion radiography at 
baseline
The frequency of radiographic features of OA present in this
subcohort is displayed in Table 1. Only a few participants
showed bone cysts, chondrocalcinosis, or subchondral bone
attrition, and these features were therefore not considered for
further analysis.
Of 70 knees without medial JSN (mJSN), 32 (46%) had no
medial (tibial or femoral) osteophytes and 38 (64%) displayed
medial osteophytes. Of 86 knees with mJSN, 76 (88%) also
displayed definite osteophytes and 10 (12%) did not. Lateral
JSN was less frequent than medial JSN (Table 1). In 80 knees
(51%), the mJSN grade was higher than the lateral JSN grade,
in 56 (36%) it was the same, and in 20 (13%) the lateral JSN
grade was higher than the medial compartment.
When taking the maximal osteophyte score of the medial tibia
and femur in each subject, 42 subjects (27%) had no medial
tibiofemoral osteophyte, 53 (34%) displayed grade 1 osteo-
phytes, 21 (13%) grade 2 osteophytes, and 40 (26%) grade
3 osteophytes.
Relation of structural changes in fixed flexion 
radiography at baseline with longitudinal changes in 
cartilage thickness (cartilage loss)
The rate of change, sensitivity to change (SRM), and signifi-
cance of the change in cartilage thickness (ThCtAB) for the
MFTC is shown in Table 2. Across all 156 subjects, the great-
est (most negative) SRM (-0.33) was observed in the cMFTC.
The mean change and SRM of cMFTC tended to be greater in
knees with the presence of medial JSN (grades 1 to 3: -2.4%;
-0.44) than in those without JSN (-1.1%; -0.22), but the differ-
ence did not attain statistical significance in the univariate
(ANOVA) or multifactorial (GLM) analysis (P = 0.66 and r2 =
2.0% after adjusting for age, sex, and BMI). Age, sex, and BMI
were no significant predictors in the multifactorial model. This
also applied to the other medial cartilage plates and subre-
gions (Table 2). The relatively greatest change (-5.6%; ccMF)
and SRM (-0.50; cMF) was found in participants with grade 2
or 3 medial JSN (Table 2). No significant effect of the pres-
ence of lateral JSN at baseline was observed on the rate of
change in the medial compartment.
Participants with and without medial femorotibial osteophytes
displayed no significant differences in the rate and sensitivity
to change in cartilage thickness (Table 3). The same observa-
tion applied to the presence and absence of lateral osteo-
phytes (data not shown).
Knees with medial femoral subchondral bone sclerosis
showed significantly greater cartilage loss in the univariate and
multifactorial analyses (up to -6.6% and SRMs up to -0.48;
Table 4) in cMF (P < 0.05; r2 = 5.7%), ccMF (P < 0.05; r2 =
4.7%), MFTC (P < 0.05; r2 = 5.3%), and cMFTC (P < 0.05; r2
= 4.5%) than those without sclerosis (up to -1.4% and SRM
= -0.23; Table 4). Again, age, sex, and BMI did not make a sig-
nificant contribution in the GLM. Knees with medial tibial
subchondral bone sclerosis also generally displayed greater
cartilage loss than those without, but the difference did not
reach statistical significance (Table 4). No significant differ-
ences in progression were detected between knees with and
without lateral tibial or femoral subchondral bone sclerosis
(data not shown).
Table 1
Frequency (n) of structural abnormalities on adjudicated reading of baseline fixed flexion radiographs
G r a d e  0G r a d e  1G r a d e  2G r a d e  3
Medial joint space narrowing 70 46 35 5
Lateral joint space narrowing 130 14 10 2
Medial tibia osteophyte 51 73 23 9
Medial femoral osteophyte 77 20 20 39
Medial subchondral tibial sclerosis 103 32 17 4
Medial subchondral femoral sclerosis 100 35 16 5
Medial tibial cysts 142 14 - -
Medial femoral cysts 155 1 - -
Medial chondrocalcinosis 139 17 - -
Medial tibial bone attrition 154 2 - -Available online http://arthritis-research.com/content/11/3/R90
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Structural changes in MRI at baseline
Thirty-four participants (22%) displayed a tibial denuded area
in MRI (>1%), with the size ranging from 1.3% to 32% of the
total area of subchondral bone (median = 10.7%). Thirty-six
participants (23%) showed a femoral denuded area that
ranged from 1.6% to 65% (median = 10.9%). Fifty knees
(32%) displayed either tibial or femoral, and 20 knees (13%)
both tibial and femoral denuded area.
Relation of structural changes in MRI at baseline with 
longitudinal changes in cartilage thickness (cartilage 
loss)
Knees with a denuded area in MFTC showed a significantly
greater cartilage loss in MT (P < 0.01; r2 = 6.4%) and cMT (P
< 0.001; r2 = 8.0%) than knees without denuded areas (Table
5). Knees with denuded areas in cMF also displayed signifi-
cantly greater cartilage loss in MT (P < 0.05; r2 = 5.3%) and
cMT (P < 0.001; r2 = 8.4%) than those without a denuded
area in cMF. These observations were consistent in the univar-
iate and multifactorial analyses. No significant differences
were observed for knees with and without denuded areas in
MT, or for other outcomes. The greatest SRM (-0.64) was
observed for the change in cMFTC in subjects with a denuded
area in cMF (Table 5).
Smaller baseline cartilage thickness in MT was significantly
associated with greater cartilage loss in MT (P < 0.05; r2 =
2.9%) and cMT (P < 0.05; r2 = 3.8%), and smaller baseline
cartilage thickness in cMF was significantly associated with
greater cartilage loss in cMF (P < 0.05; r2 = 3.5%). Thin carti-
lage in both MT and cMF (MFTC) was significantly associated
Table 2
Change in cartilage thickness (ThCtAB) over one year in all participants and in participants with and without medial femoro-tibial 
joint space narrowing (mJSN) at baseline
All (n = 156) mJSN 0 (n = 70) mJSN 1 (n = 46) mJSN 2 or 3 (n = 40)
MC% SRM P (FUvs.BL) MC% SRM P (FUvs.BL) MC% SRM P (FUvs.BL) MC% SRM P (FUvs.BL)
MT -0.5 -0.16 0.04274 -0.2 -0.09 0.4554 -0.7 -0.23 0.1215 -0.9 -0.20 0.2115
cMF -1.9 -0.30 0.00021 -1.0 -0.19 0.1244 -1.8 -0.31 0.0399 -4.4 -0.50 0.0033
MFTC -1.2 -0.31 0.00015 -0.7 -0.19 0.1231 -1.3 -0.38 0.0134 -2.5 -0.45 0.0069
cMT -0.9 -0.20 0.01505 -0.3 -0.08 0.4819 -1.0 -0.25 0.0975 -1.8 -0.31 0.0606
ccMF -2.8 -0.31 0.00013 -1.9 -0.23 0.0537 -2.8 -0.34 0.0274 -5.6 -0.45 0.0066
cMFTC -1.7 -0.33 0.00005 -1.1 -0.22 0.0704 -1.9 -0.40 0.0090 -3.2 -0.47 0.0046
The P value indicates the level of significance for changes between year one follow up (FU) versus baseline (BL) data using a paired t-test.
ccMF = central subregion of the weight bearing medial femoral condyle; cMF = weight bearing medial femoral condyle; cMFTC = central medial 
femorotibial compartment; cMT = central subregion of the medial tibia; MC% = mean change (in %); MFTC = medial femorotibial compartment; 
MT = medial tibia; SRM = standardized response mean (mean change/SD of change).
Table 3
Change in cartilage thickness (ThCtAB) over one year in participants with various grades of medial femorotibial osteophytes (mOP) 
at baseline
mOP 0 (n = 42) mOP 1 (n = 53) mOP 2 (n = 21) mOP 3 (n = 40)
MC% SRM P (FUvs.BL) MC% SRM P (FUvs.BL) MC% SRM P (FUvs.BL) MC% SRM P (FUvs.BL)
MT -1.1 -0.46 0.00475 0.0 0.01 0.94330 -1.0 -0.24 0.28311 -0.3 -0.10 0.52858
cMF -1.9 -0.35 0.02844 -1. 7 -0.31 0.02878 -2.6 -0.40 0.08254 -1.8 -0.21 0.18398
MFTC -1.5 -0.46 0.00509 -0.9 -0.23 0.10443 -1.8 -0.39 0.09264 -1.0 -0.24 0.14224
cMT -1.5 -0.42 0.00889 0.0 -0.01 0.94955 -1.7 -0.31 0.16985 -0.7 -0.15 0.35837
ccMF -2.6 -0.33 0.04059 -2.9 -0.40 0.00582 -3.5 -0.36 0.11512 -2.3 -0.20 0.21479
cMFTC -2.1 -0.42 0.00987 -1.4 -0.31 0.02639 -2.5 -0.39 0.08638 -1.4 -0.24 0.14412
The P value indicates the level of significance for changes between year one follow up (FU) versus baseline (BL) data using a paired t-test.
ccMF = central subregion of the weight bearing medial femoral condyle; cMF = weight bearing medial femoral condyle; cMFTC = central medial 
femorotibial compartment; cMT = central subregion of the medial tibia; MC% = mean change (in %); MFTC = medial femorotibial compartment; 
MT = medial tibia; SRM = standardized response mean (mean change/SD of change).Arthritis Research & Therapy    Vol 11 No 3    Eckstein et al.
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with greater cartilage loss in cMT (P < 0.05; r2 = 4.2%) after
adjusting for age, sex, and BMI in the GLM.
Discussion
This study investigates the relation of compartment-specific
structural radiographic knee and MRI cartilage status at base-
line with medial femorotibial cartilage thickness loss over one
year as measured by 3 Tesla MRI. The results indicate that
knees with more advanced medial femorotibial disease display
greater cartilage loss than those with less advanced disease.
Osteophytes, which represent early radiographic features of
OA, did not predict cartilage loss in the current study, but
knees with medial JSN tended to exhibit greater cartilage loss
in the MFTC than those without JSN, although the relation was
not significant. Subchondral femoral sclerosis (radiography),
denuded subchondral bone area (MRI), and lower cartilage
thickness (in MRI) at baseline displayed significant relations
with at least some of the outcome measures of medial carti-
lage loss, all of these representing measures of relatively
advanced disease. Whereas in the entire cohort the greatest
SRM was -0.33 (change in cMFTC), the SRM was -0.47 in
knees with grades 2/3 medial JSN, -0.46/-0.47 in knees with
tibial and femoral subchondral sclerosis, and -0.64 in knees
with denuded areas in the weight-bearing femur.
The subcohort examined here was the first one made public by
the OA Initiative. It represents a stratified random sample of
subjects with complete baseline and 12-month imaging data
available as of April 2006, with strata roughly equal by gender
and clinical/imaging site. Although it was not intended to be a
random sample of the entire progression subcohort, the156
subjects analyzed show baseline characteristics similar to the
Table 4
Change in cartilage thickness (ThCtAB) over one year in participants with and without medial subchondral bone sclerosis at 
baseline
No tibial sclerosis (n = 103) Tibial sclerosis (n = 53) No femoral sclerosis (n = 100) Femoral sclerosis (n = 56)
MC% SRM P (FUvs.BL) MC% SRM P (FUvs.BL) MC% SRM P (FUvs.BL) MC% SRM P (FUvs.BL)
MT -0.3 -0.13 0.19393 -0.9 -0.22 0.12093 -0.3 -0.11 0.26937 -1.0 -0.24 0.08337
cMF -1.4 -0.23 0.02012 -3.2 -0.46 0.00168 -0.8 -0. 17 0.08584 -4.6 -0.48 0.00064
MFTC -0.9 -0.24 0.01704 -2. 0 -0.46 0.00168 -0.6 -0.19 0.05783 -2.7 -0.48 0.00074
cMT -0.5 -0.14 0.15907 -1.6 -0.29 0.04127 -0.4 -0.12 0.22676 -1.7 -0.31 0.02597
ccMF -2.3 -0.27 0.00678 -4.2 -0.42 0.00369 -1.4 -0.23 0.02596 -6.6 -0.44 0.00171
cMFTC -1.4 -0.27 0.00639 -2.7 -0.46 0.00141 -0.9 -0.24 0.01730 -3.7 -0.47 0.00094
The P value indicates the level of significance for changes between year one follow up (FU) versus baseline (BL) data using a paired t-test.
ccMF = central subregion of the weight bearing medial femoral condyle; cMF = weight bearing medial femoral condyle; cMFTC = central medial 
femorotibial compartment; cMT = central subregion of the medial tibia; MC% = mean change (in %); MFTC = medial femorotibial compartment; 
MT = medial tibia; SRM = standardized response mean (mean change/SD of change).
Table 5
Change in cartilage thickness (ThCtAB) over one year in participants with without and with more than 1% denuded area (dAB) in the 
medial tibia or the medial weight-bearing femoral condyle at baseline
No MFTC.dAB > 1% (n = 106) MFTC.dAB > 1% (n = 50) MT.dAB > 1% (n = 37) cMF.dAB > 1% (n = 36)
MC% SRM P (FUvs.BL) MC% SRM P (FUvs.BL) MC% SRM P (FUvs.BL) MC% SRM P (FUvs.BL)
MT -0.1 -0.04 0.69131 -1.6 -0.43 0.00602 -1.6 -0.42 0.02582 -1.9 -0.51 0.00539
cMF -1.9 -0.34 0.00073 -2.2 -0.25 0.09440 -1.4 -0.15 0.41551 -4.4 -0.51 0.00540
MFTC -1.0 -0.30 0.00256 -1.9 -0.35 0.02198 -1.5 -0.27 0.14541 -3.0 -0.57 0.00232
cMT -0.3 -0.07 0.47903 -2.4 -0.46 0.00318 -2.5 -0.42 0.02605 -3.4 -0.62 0.00105
ccMF -2.9 -0.35 0.00044 -2.7 -0.23 0.12063 -1.8 -0.14 0.44502 -5.4 -0.47 0. 01001
cMFTC -1.5 -0.32 0.00134 -2.5 -0.38 0.01261 -2.2 -0.29 0.11271 -4.2 -0.64 0.00074
The P value indicates the level of significance for changes between year one follow up (FU) versus baseline (BL) data using a paired t-test.
ccMF = central subregion of the weight bearing medial femoral condyle; cMF = weight bearing medial femoral condyle; cMFTC = central medial 
femorotibial compartment; cMT = central subregion of the medial tibia; MC% = mean change (in %); MFTC = medial femorotibial compartment; 
MT = medial tibia; SRM = standardized response mean (mean change/SD of change).Available online http://arthritis-research.com/content/11/3/R90
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entire OA Initiative progression subcohort (n = 1389; age
range 45 to 79 years; 57% women with an age of 61.5 ± 8.9
years and a BMI of 30.8 ± 5.4; 43% men with an age of 61.1
± 9.3 years and a BMI of 29.8 ± 4.1). A breakdown of calcu-
lated KLGs for all right knees for the entire progression subco-
hort in comparison with the subsample investigated here (2%
vs. 11% KLG 0, 13% vs. 19% KLG1, 31% vs. 36% KLG 2,
39% vs. 30% KLG 3, and 15% vs. 4% KLG 4) shows that the
current sample included more cases with no or possible radi-
ographic OA (KLG0/1) and fewer cases with severe radio-
graphic OA (KLG4) than the right knees of the entire
progression subcohort, but both samples span all grades of
radiographic OA.
Although a larger set of image data has been made public by
the OA Initiative, central and compartment-specific radio-
graphic readings (on which these analyses relied) have so far
only been performed for the subsample used in this analysis.
The statistical power of the current study is therefore limited by
the relatively small sample size, which also introduces the
potential problem of type 2 error, given the relatively large
number of features examined. However, the features examined
have been analyzed, but were not interpreted in isolation, in
that most of the features found to be associated with higher
rates of cartilage loss and greater SRMs were features of
advanced structural disease. The current results should never-
theless be viewed as exploratory and must be confirmed in
another (larger) sample, before recruitment approaches are
based on any of the radiographic or MRI features investigated
here. Also, the specific radiographic and MRI features studied
must be seen in the context of other potentially predisposing
risk factors, such as meniscal extrusion and damage [20-22],
bone marrow alterations [21-23], focal cartilage defects
[24,25], and limb alignment [26-30], as some of these may be
directly or indirectly associated with the described compart-
ment-specific radiographic or MRI features.
Additionally, there exist other potential predisposing factors of
structural progression, for which less clear evidence or even
contradictory results have been provided, including pain, joint
function, physical activity levels [31], synovitis (effusion) [32],
sex hormone levels [33,34], and serum or urine biomarkers
[35], which eventually need to be taken into account. Another
limitation of the study is that, given the limited number of cases
and the greater progression observed in the MFTC in this sub-
cohort [9-11], the analysis was deliberately limited to MFTC
outcomes, whereas some participants also showed progres-
sion in the lateral compartment. Only femorotibial, but not fem-
oropatellar, radiographic features were analyzed, again
because of the limited sample size, and because no femorop-
atellar readings have yet been provided by the OA Initiative.
Only the right knee was analyzed, because the MRI sequence
used for cartilage morphometry (FLASH) was only acquired in
the right, but not in the left knees [17], so that not all knees dis-
played radiographic and/or symptomatic OA. This, however,
allowed us to examine the potential predictive value of radio-
graphic and MRI features across knees with a relatively wide
range of radiographic status. The decision to analyze the
FLASH sequence acquired in all right knees, rather than the
DESS sequence that was available for both knees, was made
to allow to directly link the results to previous findings in other
cohorts, which have to date been based on FLASH or SPGR
sequences.
The strength of the current study is that it uses validated quan-
titative MRI technology as a measure of structural disease pro-
gression, which has been shown to be more powerful in
revealing risk factor associations than semi-quantitative scor-
ing of cartilage status [28]. Cartilage loss, as measured with
MRI over relatively short periods (1 or 2 years), has been
shown to be associated with cartilage loss over longer periods
(4.5 years) [36] and with a clinical outcome of OA, specifically
knee arthroplasty [37], which makes it a very promising surro-
gate endpoint. Also, the current analysis relied on central radi-
ographic readings of the OA Initiative imaging data, which was
adjudicated in case of discrepancy between two independent
readers, and has been shown to deviate in a substantial
number of cases from the site readings used for the purpose
of recruiting participants for the OA Initiative [11]. Despite the
many structural features examined and lack of statistical signif-
icance for some of these, the features suggestive of advanced
disease pointed towards greater longitudinal cartilage loss
compared with knees with less advanced disease.
Felson and colleagues [38] reported that higher osteophyte
scores modestly increased the risk of OA progression
(defined by increasing JSN over 30 months), in particular
when compartment-specific relations were analyzed. The
authors mentioned that this association became weaker to
non-significant when adjusting for limb alignment. Wolfe and
Lane [39] reported that JSN at baseline was a strong predictor
of OA progression (defined by advancing to radiographic JSN
grade 3) in more than 1500 patients, whereas BMI and osteo-
phytes were less predictive and only contributed in partici-
pants with no JSN at baseline. Mazzuca and colleagues [40]
also found the progression of JSN over 30 months to be
inversely related to baseline joint space width (JSW) and Le
Graverand and colleagues [41] the reduction in JSW to be
greater in knees with JSN at baseline, using fluoroscopically
standardized knee radiographs. In contrast to these and our
current findings, Bruyere and colleagues [42] reported
patients in the highest quartile of baseline JSW to experience
more severe cartilage loss than those in the lowest quartile
and thus recommended the inclusion of participants with less
severe OA (high JSW, no JSN) in disease-modifying OA drug
trials.
Few studies have so far investigated the relationship between
MRI-based cartilage loss and radiographic features of OA at
baseline. Raynauld and colleagues [21] found no significantArthritis Research & Therapy    Vol 11 No 3    Eckstein et al.
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association of MRI-based cartilage loss over 24 months with
the radiographic JSW at baseline. However, another analysis
from the same group [22] reported that cartilage loss in the
central aspects of the femorotibial cartilage plates was asso-
ciated with smaller JSW and higher grades of JSN at baseline,
and the results of our current analysis are in agreement with
these findings. Wluka and colleagues [43] reported the initial
cartilage volume (in MRI) to be the most significant determi-
nant of tibial cartilage loss (volume change with MRI), partici-
pants with high initial cartilage volume experiencing more
severe cartilage loss than those with smaller cartilage volumes
at baseline. Our current results are in direct disagreement with
these observations in that we find a greater cartilage loss in
participants with low initial cartilage thickness and with already
denuded subchondral bone at baseline.
To our knowledge, no previous study has identified a relation
between subchondral bone sclerosis at baseline and MRI-
based cartilage loss. Buckland-Wright [44] observed that the
subchondral cortical plate and adjacent trabeculae thicken in
OA, often prior to the onset of JSN. However, it was also
reported that sclerosis did not increase in knees until the
medial JSW was less than 1.5 mm. Bruyere and colleagues
[45] found tibial bone mineral density (BMD) as measured by
dual x-ray absorptiometry to independently predict medial JSN
over a one-year period in radiography, with patients in the low-
est BMD quartile experience less JSN than those in the high-
est quartile. These observations are supported by our current
MRI-based findings of increased cartilage loss in participants
with subchondral sclerosis.
The greatest sensitivity to change (SRM) in this study was
observed in subcohorts selected by baseline denuded area
and initial cartilage thickness in MRI (up to -0.64). From the
standpoint of recruiting patients for clinical trials, it must, how-
ever, be remembered that MRI is very costly and therefore can-
not realistically be used as a screening tool. Using
compartment-specific features of fixed flexion radiographs
(specifically JSN and subchondral sclerosis), however, the
SRM increased from -0.33 in the entire cohort to -0.47 for
those with JSN grade 2 or 3 or participants with subchondral
sclerosis. Such increases in SRM involve substantial savings
in either the cohort size or the study duration in clinical trials
and may thus justify the use of radiography as a screening tool
in disease-modifying OA drug efficacy studies. Although it is
currently unclear at which radiographic stage of radiographic
OA disease-modifying drugs will be most effective, the current
data can provide a reasonable basis for power calculations of
the number or participants (with specific radiographic fea-
tures) entered into a trial, if the effect of a disease-modifying
OA drug is to be demonstrated.
Conclusions
This study indicates that radiographic and MRI cartilage mor-
phometry features of advanced disease (JSN, subchondral
bone sclerosis, denuded bone areas, and low baseline carti-
lage thickness) appear to be associated with longitudinal car-
tilage loss in OA. Particularly radiography may be suited for
selecting patients with a higher likelihood of fast progression
in studies that try to demonstrate the cartilage preserving
effect of disease-modifying OA drugs.
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